Researchers find new form of cell division
Researchers at the University of Wisconsin Carbone Cancer Center have discovered a new form of cell division in human cells.
Dec 17, 2012
5 / 5 (7)
4
| 
Dec 17, 2012
5 / 5 (7)
4
|
Life work culminates in testing of cancer therapy in humans
A cancer-fighting antibody identified by a researcher working at The University of Queensland and Queensland Institute of Medical Research (QIMR) will today be used to treat the first patient, in a Phase 1 clinical trial.
Mar 24, 2011
5 / 5 (2)
0
Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities
Results from a study published in Blood, the Journal of the American Society of Hematology reveal a close relationship between pulmonary arterial hypertension (PAH)—exceedingly high blood pressure in the arteries carryi ...
Feb 28, 2011
not rated yet
0
Drug combination shows promise for newly diagnosed blood cancer patients, study finds
A new three-drug combination used to treat the blood cancer multiple myeloma may be effective as a front-line therapy for newly diagnosed patients, according to a study led by the University of Michigan Comprehensive Cancer ...
Dec 09, 2010
not rated yet
0
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College ...
Dec 06, 2010
not rated yet
0
Phase I trial indicates ponatinib may thwart most resistant CML
A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from ...
Dec 06, 2010
not rated yet
0
New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients
An updated joint guideline by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) advises physicians about the appropriate use of erythropoiesis-stimulating agents (ESAs), a class ...
Oct 26, 2010
not rated yet
0
Inhaling nitric oxide eases pain crises in sickle cell patients
Inhaling nitric oxide appears to safely and effectively reduce pain crises in adults with sickle cell disease, researchers report.
Oct 19, 2010
not rated yet
1
Novel regulatory process for T cells may help explain immune system diseases
A newly identified regulatory process affecting the biology of immune system T cells should give scientists new approaches to explore the causes of autoimmunity and immune deficiency diseases.
Oct 19, 2010
4 / 5 (1)
0
|
Oncologists play key role in fight against smoking
(PhysOrg.com) -- Oncologists should consider it their professional duty to set a healthy example by not smoking and by advocating against tobacco use locally and internationally, two Emory faculty members argue in an article ...
Sep 13, 2010
5 / 5 (1)
0
Ode to a fibrin polymer -- How a student's verse made the clinical chemistry journal
(PhysOrg.com) -- Some things are more fun to learn than others, and the coagulation cascade has traditionally been ranked among the less fun. Sure, it's important--without it we'd all bleed to death--but it is devilishly ...
Sep 09, 2010
not rated yet
0
Study finds low liver cancer survival rates among Laotian/Hmong-Americans
Among Asian-Americans living in California, Laotian/Hmong-Americans have the lowest survival rates for the most common type of liver cancer, a new study by researchers with the UC Davis School of Medicine has found.
Sep 09, 2010
5 / 5 (1)
0
Genetic markers could predict prostate cancer in younger men, study finds
Prostate cancer has become more common in younger men, and it's often more aggressive in these men. A new study from researchers at the University of Michigan Comprehensive Cancer Center has found that a series of genetic ...
Jun 07, 2010
4.5 / 5 (2)
0
Green tea extract appears to keep cancer in check in majority of CLL patients
An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II clinical trial, say researchers at Mayo Clinic.
Jun 07, 2010
5 / 5 (3)
0
Phase II study of an oral therapy for Gaucher disease yields positive results
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, resear ...
May 03, 2010
not rated yet
0
